Literature DB >> 35388264

Inadvertent intralenticular Ozurdex removal.

Madhurima Roy1, Aniruddha Maiti2, Sayan Das1, Sagnik Surya Das1.   

Abstract

Entities:  

Year:  2022        PMID： 35388264      PMCID： PMC8979398          DOI： 10.4103/ojo.ojo_144_21

Source DB:  PubMed          Journal:  Oman J Ophthalmol        ISSN： 0974-620X


× No keyword cloud information.
  4 in total

1.  Accidental insertion of dexamethasone implant into the crystalline lens--12 months follow-up.

Authors:  R Chhabra; K Kopsidas; S Mahmood
Journal:  Eye (Lond)       Date:  2014-02-21       Impact factor: 3.775

2.  Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Authors:  Julia A Haller; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Jeffrey Heier; Anat Loewenstein; Young Hee Yoon; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup; Joanne Li
Journal:  Ophthalmology       Date:  2011-07-20       Impact factor: 12.079

3.  [Reliability and safety of intravitreal Ozurdex injections. The ZERO study].

Authors:  K Schmitz; M Maier; C R Clemens; F Höhn; J Wachtlin; F Lehmann; T Bertelmann; K Rüdiger; M Horn; A Bezatis; G Spital; C H Meyer
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

4.  Intralenticular Sustained-Release Dexamethasone Implant: Is It Still Effective on Macular Edema?

Authors:  Mehmet Ali Sekeroglu; Mustafa Alpaslan Anayol; Fatih Koc; Hakan Tirhis; Seyhan Sonar Ozkan; Pelin Yilmazbas
Journal:  Case Rep Ophthalmol       Date:  2016-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.